Skip to main content

CAREERS AT NLC

Investment Director

Amsterdam, Netherlands

Location
Amsterdam, Netherlands
Work
Hybrid
Employment
Not stated
Level
Director
Function
Finance
Pay
Not stated
Posted
3 months ago

About the role

Investment Director

About NLC

NLC Health Ventures is a health tech venture builder that creates and scales pre-seed and early-stage ventures across Europe.

At NLC, we foster a culture of collaboration and shared purpose, guided by our core values: Together, Open, Decisive, and Optimistic (TODO). We have a flat structure: your ideas and contributions matter more than your title, and we expect everyone to communicate openly and push back on hierarchy where it slows us down.

Your Role

We are looking for an Investment Director to lead NLC's search for new healthtech investments across Europe: sourcing and evaluating opportunities, negotiating and structuring deals, and deploying capital with discipline against market need, scalability, buyer relevance, and exit potential. You will also expand NLC's institutional partnerships with healthtech corporates and investors, and play a supporting role in strengthening the performance of priority ventures already in the portfolio.

Your mission is to turn clinical and technological innovation into measurable commercial, financing and strategic outcomes, working closely with venture CEOs, healthtech corporates, investors and strategic buyers.

Core Responsibilities: Investment Sourcing and Execution

  • Identify and evaluate new healthtech investment opportunities across Europe, applying rigorous diligence on market need, scalability, buyer relevance and exit potential.
  • Structure and negotiate new investments: deal terms, licence agreements and capital deployment.
  • Lead new venture incorporation: licence negotiation, CEO selection, legal incorporation and early strategy development.
  • Build and expand institutional partnerships with healthtech corporates and investors to strengthen deal flow and co-investment opportunities.
  • Managing team members to develop and execute venture creation and portfolio management strategy..
  • Support NLC's fundraising for Fund V alongside Partners and Investor Relations team.

Supporting Responsibilities: Portfolio and Exit Support

  • Contribute to portfolio performance reviews for priority ventures, alongside milestone tracking and prioritisation led by the venture team.
  • Help define financing and exit pathways with CEOs for priority ventures, matched to strategic buyer and institutional market requirements.
  • Support venture CEOs by sparring on strategy, team building, connecting them to development and clinical partners, service providers, advisors, capital providers, and strategic buyers.
  • Contribute to exit processes for priority ventures: target identification, data room input and negotiation support.

Your Profile

  • 8 to 15 years of experience in healthtech investing, deal sourcing, diligence, structuring or venture building.
  • Venture capital experience strongly preferred; comparable experience in corporate development, M&A or operating roles in high-growth healthtech companies also considered.
  • Track record of sourcing, evaluating and closing early-stage healthtech investments.
  • Deep healthtech domain expertise, with a sophisticated understanding of regulatory, reimbursement, clinical and commercial drivers.
  • Strong commercial judgment: able to identify what creates enterprise value and where capital is best deployed.
  • Experience negotiating licence agreements, term sheets and investment structures.
  • Institutional capital fluency and the ability to communicate investment rationale clearly to investors and Partners.
  • A natural connector who builds relationships and coalitions to source and close deals.
  • Performance-oriented, decisive, commercially sharp, low ego and aligned with NLC's mission.
  • Based in Europe, preference for the Netherlands given regular presence required in the Amsterdam office; flexibility to work remotely otherwise.

What We Offer

  • High-impact role with direct ownership of sourcing, structuring and closing NLC's healthtech investments, and a voice in shaping portfolio strategy.
  • Flat structure and direct influence on NLC's strategy.
  • Competitive salary with equity participation.
  • Meaningful work: contribute to scaling ventures that bring life-changing healthcare innovations to patients.
  • A seat at the table with global strategic buyers, institutional investors, and portfolio CEOs, plus direct mentorship from NLC's Partners.
  • Hybrid working model, based in the Netherlands with regular Amsterdam office presence and flexibility to work remotely.

Diversity & Inclusion

At NLC, we believe diverse perspectives drive better outcomes. If you’re excited about this role but don’t meet every requirement, we encourage you to apply.

Source

Posted by CAREERS AT NLC on their own hiring page, job-boards.greenhouse.io. OptiTalent shows it as published, read 07 Nov 2026 03:40 UTC; the original is the reference.

View the original ad ↗

More at CAREERS AT NLC

  • CAREERS AT NLC · Pittsburgh, Pennsylvania, United States

    ExecutiveHealthcare

    Aetherus is an early-stage medical device company developing a pocket-sized positive pressure device that gives patients rapid, drug-free relief from breathlessness while passively capturing physiologic data during treatment.

  • CAREERS AT NLC · Berlin, Germany

    ExecutiveEngineering

    The CEO holds overall responsibility for POROUS's business success and reports to the shareholders. The role is deliberately designed as an integrating leadership function with a focus on global marketing and sales.

  • CAREERS AT NLC · Remote

    RemotePart-timeExecutiveEngineering

    This startup is developing a new kind of small molecule to treat diabetic kidney disease (DKD) and other metabolic diseases.

  • CAREERS AT NLC · Hamburg, Germany

    DirectorProduct

    ROB’E is an early-stage MedTech venture developing an AI-powered robotic platform for echocardiography. The technology aims to transform cardiac imaging and enable more precise, image-guided structural heart interventions.